In patients with both mild cognitive impairment and AD, clusterin levels are elevated in the brain, cerebrospinal fluid, and blood (111–114), and accordingly CLU gene expression is elevated in these pathologic conditions (107). This evidence concerns the gene CLU and Alzheimer disease.